Tuebingen, Germany and Houston, Texas, USA, October 04, 2017 / B3C newswire / -- Immatics, a leading company in the field of cancer immunotherapy, today announced the completion of its Series E financing, raising $58 million. The Series E funding was …
BEKINDA®(i) 12 mg Phase II study successfully met its primary endpoint, improving primary efficacy outcome of stool consistency by an absolute difference of 19.4% vs. placebo and comparing favorably with previously reported outcomes from studies of Xifaxan …
Round led by Dutch life sciences investor BioGeneration Partners (BGV); other investors include David Pyott and existing shareholders; Oskar Slotboom (BGV) to join Supervisory Board Single handed Switch® technology allows for high precision suturing of …
Pneumonia, one of the diseases caused by pneumococcal bacteria, is currently the leading single killer of young children worldwide, despite advances in prevention and treatment $29.4 million USD grant from the Bill & Melinda Gates Foundation will …
RedHill has curtailed the target sample size in the ongoing first Phase III study with RHB-104 for Crohn’s disease (MAP US) from 410 to approximately 325 subjects, of which 322 have been enrolled to date, while maintaining statistical power of over 80% …
Ravensburg, Germany, September 28, 2017 / B3C newswire / -- At a cornerstone ceremony, Vetter officially signaled the start of a project for the creation of a new administration building at its Ravensburg Schuetzenstrasse site. Scheduled to be completed by …
Zurich, Switzerland, September 27, 2017 / B3C newswire / -- Since 1998, the Swiss Biotech Association (SBA) represents the interests of the Swiss biotech industry in Switzerland and abroad. The Swiss biotech industry is one of the most innovative and …
San Ramon, CA, USA, September 27, 2017 / B3C newswire / -- rfxcel will expand its capability to enable Life Sciences companies to meet serialization and regulatory compliance needs in the European territories. The company, which already has a presence in 4 …
Vienna, Austria September 21, 2017 / B3C newswire / -- OncoQR ML GmbH announced today that even a single therapeutic vaccine based on its proprietary S-TIR™ platform technology, is able to induce the killing of tumor target expressing cells by …
Vmax™ Express has a more rapid doubling time and generates greater biomass to yield larger amounts of soluble recombinant protein. Heidelberg, Germany, September 20, 2017 / B3C newswire / -- BioCat GmbH in Heidelberg, Germany, announced today a …
Announcing the Single-Cell Printer for documented isolation of cells in clonal cell line development Sunnyvale, Calif., USA and Freiburg, Germany, September 19, 2017 / B3C newswire / -- Molecular Devices, LLC, a leader in protein and cell biology …
Helsinki, Finland and Stockholm, Sweden, September 19, 2017 / B3C newswire / -- Aplagon Oy (“Aplagon”) and Cadila Pharmaceuticals Sweden AB today announced a development and commercialization agreement for Aplagon’s lead APAC product. APACs are proprietary …
VarmX’s lead compound PseudoXa is based on snake venom properties, and addresses unmet medical need for safe and effective prevention and treatment of bleeding in patients taking factor Xa inhibitors Product development based on R&D performed by one of …
Deqing, China, September 18, 2017 / B3C newswire / -- Shuwen Biotech announced today that it has received CE-IVD marking for its EGFR real time PCR detection kit allowing the company to market its kit in countries that recognize the designation. The CE …
Uppsala, Sweden, September 18, 2017 / B3C newswire / -- Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, is pleased to announce the launch of EVOLUTE® HYDRO, solid phase extraction …
Sandwich, UK, September 14, 2017 / B3C newswire / -- Levicept Ltd., an asset-centric biotechnology company focused on the development of LEVI-04, a first-in-class treatment for chronic pain indications, today announces that it has commenced its Phase I …
Neubau mit etwa 25.000 Quadratmetern Mit rund 42 Mio. Euro die größte Einzelinvestition des Sartorius Campus Gebäude ist durch besondere Konstruktion gegen Vibrationen geschützt Göttingen, 13. September 2017 / B3C newswire / -- Mit dem neuen Gebäude für …
Esomeprazole Strontium Delayed-Release (DR) Capsules 49.3 mg is an FDA-approved, proprietary, prescription proton pump inhibitor (PPI) indicated for adults for the treatment of gastroesophageal reflux disease (GERD) and other gastrointestinal (GI) …
Last of Teva's three glatiramer so-called HBr patents revoked Nijmegen, the Netherlands, September 13, 2017 / B3C newswire / -- Yesterday, in opposition proceedings filed by inter alia Synthon, the Technical Board of Appeal (TBA) of the European Patent …
Combined business delivers world-leading imaging capabilities to drive improved decision-making from early drug discovery to late-phase clinical development Boston, MA, USA, September 12, 2017 / B3C newswire / -- Invicro, LLC, a leading provider of imaging …
06 days 23:58:45
